At a glance
ClinicalIndex Comparison RecordN/ACompleted· 228 enrolled
Drug / intervention
Low Risk Proton Radiation +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Hypofractionated Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate
In Brief
A clinical study evaluating Low Risk Proton Radiation and Intermediate Risk Proton Radiation for Prostate Cancer. Completed, enrolled 228 participants across 1 site.
Detailed Summary
The purpose of this trial is to give a shorter course (5 ½ weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedJun 2008
Primary CompletionJun 2012
Study CompletionApr 2022
TodayJul 2026
First PostedJun 6, 2008
Enrollment StartApr 1, 2008
Primary CompletionJun 1, 2012
Study CompletionApr 25, 2022
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 18.1 years ago
Interventions
Low Risk Proton Radiationradiation
Intermediate Risk Proton Radiationradiation